While the ASX falters, one small-cap is booming. The share price of Rhythm Biosciences Ltd [ASX:RHY] is up 127% at time of writing. Surging on the back of an update in regards to the company’s cancer screening tech.
World Markets: Global Insights into Financial Trends and Investment Opportunities
When concerned with the global economy, it’s important to look beyond the powerhouses that are often in the spotlight, and to look at the various emerging markets operating just off stage.
Today’s biggest emerging markets (BEMs), include Argentina, Brazil, China, India, Indonesia, Mexico, Poland, South Africa, South Korea and Turkey. Not as big, but still making impact, are Egypt, Iran, Nigeria, Pakistan, Russia, Saudi Arabia, Taiwan, and Thailand.
NZ Banks Stop Dividends: What This Means for the Aussie Big Four
The outlook for Australia’s Big Four banks has worsened this morning, with the Reserve Bank of New Zealand (RBNZ) announcing a freeze on all dividends. All of Australia’s banks have opened lower today with Australia and New Zealand Banking Group Ltd [ASX:ANZ] and National Australia Bank Ltd [ASX:NAB] the hardest hit
What Does COVID-19 Mean for a2 Milk’s Share Price? (ASX:A2M)
New Zealand-based The a2 Milk Company Ltd [ASX:A2M] shares are among a select few that have risen during the coronavirus pandemic. Since the beginning of the year shares in the milk producer are up nearly by 20%, while the ASX 200 has reversed 21% over the same period
What’s Happening with SelfWealth’s Share Price? (ASX:SWF)
he SelfWealth Ltd [ASX:SWF] share price has had a turbulent past few months — like many other companies. SWF has made a name for itself by going after the banks’ brokerage profits. With the latest round of stimulus introduced by the Australian government, it seems investors want back in with the banks
What Happens Next? Is the Six-month ‘Job Keeper’ Hiatus a Time Bomb?
Is the economy so royally stuffed that the six-month ‘Job Keeper’ hiatus is merely a time bomb set to explode later on?
Will Cellmid Bounce Back from Its Trading Halt? (ASX:CDY)
Cellmid Ltd. [ASX:CDY], an Australian based biotechnology company, went into a trading halt on 20 March 2020 after falling to a close share price the previous day of $0.09.